Cargando…

The risk and safety profile of electronic nicotine delivery systems (ENDS): An umbrella review

BACKGROUND: Balancing electronic nicotine delivery systems (ENDS) health communication between limiting the harm for new users while offering current smokers the benefits of reduced-risk products is challenging. This umbrella review aims to summarize the evidence about ENDS risk and safety health pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Asfar, T, Maziak, W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593968/
http://dx.doi.org/10.1093/eurpub/ckac129.638
_version_ 1784815294849482752
author Asfar, T
Maziak, W
author_facet Asfar, T
Maziak, W
author_sort Asfar, T
collection PubMed
description BACKGROUND: Balancing electronic nicotine delivery systems (ENDS) health communication between limiting the harm for new users while offering current smokers the benefits of reduced-risk products is challenging. This umbrella review aims to summarize the evidence about ENDS risk and safety health profile to inform ENDS health communication strategies. METHODS: Six databases were searched for systematic reviews presenting evidence on ENDS health effects. Ninety reviews divided into 5 categories were included: toxicity = 20, health effects = 40, smoking cessation = 24, transition to combustible cigarettes (CCs) = 13, and industry claims = 4. Findings were summarized narratively. Meta-analyses were conducted when appropriate. Quality assessment was conducted using the Measurement Tool to Assess Systematic Reviews. The Institute of Medicine's Levels of Evidence Framework was used to classify the evidence into high-level, moderate, limited-suggestive, and limited-not-conclusive. RESULTS: We found high-level evidence that ENDS exposes users to toxic substances; increases the risk of asthma; leads to nicotine dependence; causes serious injuries due to explosion or poisoning; increases smoking cessation in clinical trials but not in observational studies; increases CCs initiation; and exposure to ENDS marketing increases its use/intention-to-use. Evidence was moderate for ENDS association with mental health and substance use, and limited-not-conclusive for its association with cardiovascular, cancer, ear, ocular, and oral diseases, and pregnancy outcomes. CONCLUSIONS: Currently, ENDS communication can focus on high-level evidence related to ENDS association with toxicity, nicotine addiction, respiratory disease, ENDS-specific harm (explosion, poisoning), and anti-ENDS industry sentiment. Further research is needed to assess the full spectrum of ENDS health profiles. KEY MESSAGES: • Further research is needed to establish the risk and safety health profile of ENDS with consideration of the wide variety of ENDS, their frequency of use, and different segments of the population. • More prospective cohort studies that take place over longer time periods and with larger sample sizes are necessary to gauge accurately the short- and long-term health-related risks of ENDS.
format Online
Article
Text
id pubmed-9593968
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95939682022-11-22 The risk and safety profile of electronic nicotine delivery systems (ENDS): An umbrella review Asfar, T Maziak, W Eur J Public Health Parallel Programme BACKGROUND: Balancing electronic nicotine delivery systems (ENDS) health communication between limiting the harm for new users while offering current smokers the benefits of reduced-risk products is challenging. This umbrella review aims to summarize the evidence about ENDS risk and safety health profile to inform ENDS health communication strategies. METHODS: Six databases were searched for systematic reviews presenting evidence on ENDS health effects. Ninety reviews divided into 5 categories were included: toxicity = 20, health effects = 40, smoking cessation = 24, transition to combustible cigarettes (CCs) = 13, and industry claims = 4. Findings were summarized narratively. Meta-analyses were conducted when appropriate. Quality assessment was conducted using the Measurement Tool to Assess Systematic Reviews. The Institute of Medicine's Levels of Evidence Framework was used to classify the evidence into high-level, moderate, limited-suggestive, and limited-not-conclusive. RESULTS: We found high-level evidence that ENDS exposes users to toxic substances; increases the risk of asthma; leads to nicotine dependence; causes serious injuries due to explosion or poisoning; increases smoking cessation in clinical trials but not in observational studies; increases CCs initiation; and exposure to ENDS marketing increases its use/intention-to-use. Evidence was moderate for ENDS association with mental health and substance use, and limited-not-conclusive for its association with cardiovascular, cancer, ear, ocular, and oral diseases, and pregnancy outcomes. CONCLUSIONS: Currently, ENDS communication can focus on high-level evidence related to ENDS association with toxicity, nicotine addiction, respiratory disease, ENDS-specific harm (explosion, poisoning), and anti-ENDS industry sentiment. Further research is needed to assess the full spectrum of ENDS health profiles. KEY MESSAGES: • Further research is needed to establish the risk and safety health profile of ENDS with consideration of the wide variety of ENDS, their frequency of use, and different segments of the population. • More prospective cohort studies that take place over longer time periods and with larger sample sizes are necessary to gauge accurately the short- and long-term health-related risks of ENDS. Oxford University Press 2022-10-25 /pmc/articles/PMC9593968/ http://dx.doi.org/10.1093/eurpub/ckac129.638 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Parallel Programme
Asfar, T
Maziak, W
The risk and safety profile of electronic nicotine delivery systems (ENDS): An umbrella review
title The risk and safety profile of electronic nicotine delivery systems (ENDS): An umbrella review
title_full The risk and safety profile of electronic nicotine delivery systems (ENDS): An umbrella review
title_fullStr The risk and safety profile of electronic nicotine delivery systems (ENDS): An umbrella review
title_full_unstemmed The risk and safety profile of electronic nicotine delivery systems (ENDS): An umbrella review
title_short The risk and safety profile of electronic nicotine delivery systems (ENDS): An umbrella review
title_sort risk and safety profile of electronic nicotine delivery systems (ends): an umbrella review
topic Parallel Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593968/
http://dx.doi.org/10.1093/eurpub/ckac129.638
work_keys_str_mv AT asfart theriskandsafetyprofileofelectronicnicotinedeliverysystemsendsanumbrellareview
AT maziakw theriskandsafetyprofileofelectronicnicotinedeliverysystemsendsanumbrellareview
AT asfart riskandsafetyprofileofelectronicnicotinedeliverysystemsendsanumbrellareview
AT maziakw riskandsafetyprofileofelectronicnicotinedeliverysystemsendsanumbrellareview